Maternal circulating sFlt-1/placental growth factor is a biomarker of fetal death associated with placental lesions of maternal vascular malperfusion
The maternal sFlt-1/PlGF ratio identifies pregnancies with fetal or neonatal death associated with placental MVM, particularly between 28 and 36 weeks' gestation.
Authors
- Janet Moore (ORCID: https://orcid.org/0000-0003-1750-8794)
- Dereje W. Gudicha
- R. Romero
- Elizabeth M. McClure (ORCID: https://orcid.org/0000-0001-8659-5444)
- Awoniyi O. Awonuga (ORCID: https://orcid.org/0000-0002-0864-5394)
- Shivaprasad S. Goudar (ORCID: https://orcid.org/0000-0002-8680-7053)
- Arun Meyyazhagan
- Shiyam Sunder Tikmani (ORCID: https://orcid.org/0009-0001-0523-205X)
- Jean Kim (ORCID: https://orcid.org/0000-0002-2207-6263)
- S B Patil
- Afia Zafar
- S Yogeshkumar
- Najia K. Ghanchi
- Sarah Saleem
- Robert L. Goldenberg
- Manjunath Somannavar
- Tinnakorn Chaiworapongsa
- Sunilkumar BK
- Adi L. Tarca
- Imran Ahmed
Institutions
- Aga Khan University (PK)
- RTI International (US)
- Wayne State University (US)
- University of Michigan (US)
- Shamnur Shivashankarappa Institute of Medical Sciences & Research Centre (IN)
- Jawaharlal Nehru Medical College (IN)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- Christ University (IN)
- Columbia University (US)
- Michigan State University (US)
Publication Details
- Journal
- Journal of Perinatal Medicine
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1515/jpm-2025-0624
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00